In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
In hospitals with better nurse work environments, ischemic stroke patients experience lower odds of readmissions and shorter lengths of stay.
The comprehensive net clinical outcomes of low- and high-dose edoxaban was evaluated for stroke in atrial fibrillation.
Subclinical hypothyroidism is reportedly associated with an increased risk of adverse events in patients undergoing coronary angioplasty.
Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.
Mortality risk lower with PDE5i treatment versus alprostadil treatment; similar links seen for MI, heart failure, CV mortality risk.
Increased exposure linked to significantly increased rates of incident keratinocyte carcinoma, melanoma in adults ≥66 years.
This study suggests that lowering SBP <145 mmHg before oral anticoagulation initiation may decrease risk for hemorrhagic stroke in patients with hypertension and atrial fibrillation.
Racial inequities in cardiovascular health care persist in rural areas of the United States.
The recall was initiated due to reports of stent fractures and endoleaks.
Treatment with rituximab and immunoglobulin levels may increase risk for COVID-19-related death in ANCA-associated vasculitis.
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
Exercise therapy and lower extremity revascularization both improve walking performance in symptomatic patients with peripheral artery disease, concluded researchers after a comprehensive review of several randomized controlled trials.
Patients with resistant hypertension and hypokalemia are likely to have primary aldosteronism, which may be at the root of their condition. Screening rates patients for primary aldosteronism doesn’t appear to be common practice.
During follow-up, patients had increased risk for all-cause mortality.
A substantial number of employees and trainees working at medical centers have experienced major stress and work disruptions because of the COVID-19 pandemic.
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
SGLT2i use was linked to reduced mortality and morbidity in a real-world cohort of patients with heart failure and diabetes.
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
The BBV152 vaccine, produced by Bharat Biotech International, was a whole-virion -propiolactone-inactivated SARS-CoV-2 vaccine formulated by Algel-alum or Algel-IMDG adjuvants.